Shuko Harada

The University of Alabama

United States

Research Interests

Explore related searches

Contact this professor

Google Scholar

Articles (26)

Collaborators (10)

João Lobo

Lecturer in Pathology - Master degree in Medicine

Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar

Ahmed Elkhanany

Assistant Professor

UNITED STATES

George Netto

University of Pennsylvania Perelman School of Medicine

UNITED STATES

Xiao Huang

The University of Texas MD Anderson Cancer Center

UNITED STATES

Carlos Prieto-Granada

Assistant Professor

Vanderbilt University Medical Center

UNITED STATES

David Suster

department of pathology university of alabama at birmingham birmingham al usa

UNITED STATES

David Crossman

Assistant Professor/Bioinformatics Director

The University of Alabama

UNITED STATES

Alexander Mackinnon

The University of Alabama

UNITED STATES

Thomas Winokur

The University of Alabama

UNITED STATES

Cristina Magi‐Galluzzi

UNITED STATES

Shuko Harada

Research Interests

Explore related searches

Contact this professor

Articles (26)

Primary Ewing Sarcoma of the Kidney

SFPQ::TFE3-rearranged PEComa: Differences and analogies with renal cell carcinoma carrying the same translocation

Association between p16INK4A expression and a treatment response to CDK4/6 inhibitor in advanced breast carcinoma

A Genomic Alteration in GATA3 Affects Treatment Responses With a CDK4/6 Inhibitor Collaborating With p18&lt;sup&gt;INK4C&lt;/sup&gt; Expression in Advanced Breast Carcinoma.

Predictive biomarkers for immune checkpoint inhibitor (ICI) and poly (ADP-ribose) polymerase (PARP) inhibitor (PARPi) in advanced-stage breast carcinoma

Hepatic adenomas in males: Is molecular characterization helpful in guiding its management?

p53 protein expression patterns associated with TP53 mutations in breast carcinoma

Non-small cell lung carcinoma with clear cell features: a clinicopathologic, immunohistochemical, and molecular study of 31 cases

Extraosseous Ewing’s Sarcoma/Primitive Neuroectodermal Tumor of the Pancreas

Molecular Characterization of Juxtaglomerular Cell Tumors: Evidence of Alterations in MAPK–RAS Pathway

In Reply

Non-Small Cell Lung Carcinoma with Clear Cell Features and FGFR3::TACC3 Gene Rearrangement: Clinicopathologic and Next Generation Sequencing Study of 7 Cases

Navigating Next-Generation Sequencing Laboratory Developed Tests A Critical Look at Proficiency Testing, US Food and Drug Administration Regulations, and Clinical Laboratory Performance

Inflammatory Giant Cell Carcinoma of the Lung: Clinicopathologic, Immunohistochemical, and Next-generation Sequencing Study of 14 Cases

Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma

Pathologic, immunologic, and clinical analysis of the microsatellite instability phenotype in endometrial carcinoma

An Unusual Benign Uterine Stromal Spindle Cell Tumor Harboring JAZF1::BCORL1

Molecular characterization of visible low-grade dysplastic lesions in patients with inflammatory bowel disease

Cutaneous malignant glomus tumor with an MIR143(CARMN)::NOTCH2 fusion

Nested and Large Nested Subtypes of Urothelial Carcinoma of the Upper Urinary Tract: A Multi-institutional Study

PD-L1 (22C3) Expression Correlates with Clinical and Molecular Features of Lung Adenocarcinomas in Cytological Samples

Performance of Idylla KRAS assay on extracted DNA and de-stained cytology smears: Can we rescue small sample?

The diagnostic utility of RNA-based fusion panel testing ordered by pathologists in challenging cases

Utility of Single-Gene Testing in Cancer Specimens

Suppression of SIN3A by miR-183 Promotes Breast Cancer Metastasis

New Approaches and Strategies for Proficiency Testing for Next-Generation Sequencing-Based Oncology Assays

Collaborators (10)

João Lobo

Ahmed Elkhanany

George Netto

Xiao Huang

Carlos Prieto-Granada

David Suster

David Crossman

Alexander Mackinnon

Thomas Winokur

Cristina Magi‐Galluzzi

How do I reach out?

Meet Kite AI

A Genomic Alteration in GATA3 Affects Treatment Responses With a CDK4/6 Inhibitor Collaborating With p18<sup>INK4C</sup> Expression in Advanced Breast Carcinoma.